Developer docs
API playgroundTry for free, no card

Search company profiles

BIO Protocol

Full company profile

uuid000021t

Namestring
BIO Protocol
Legal namestring
BIO.XYZ Association
Websiteurl
bio.xyz
Company typeenum
Private
Founded yearint
2022
Descriptiontext

BIO Protocol, operated by the Swiss-domiciled BIO.XYZ Association in Zug, is a decentralized science (DeSci) platform built primarily on Ethereum with Solana expansion, that provides financial infrastructure for early-stage biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs) and tokenized intellectual property. The platform enables researchers to raise funds directly from global communities of patients, researchers, and crypto users, bypassing traditional grant gatekeepers and venture capital, while creating on-chain governance for research prioritization and commercialization. Core technology components include the Launchpad V2 (fixed-price token sale mechanism), BioXP (a non-transferable point system determining allocation priority in oversubscribed sales), veBIO (a 52-week vote-escrowed governance mechanism), and BioAgents — autonomous AI-powered scientific agents including Aubrai (built with VitaDAO for longevity) and BIO Copilot for hypothesis generation and research acceleration.

The product portfolio spans core protocol infrastructure (Launchpad V2, Dashboard, Portfolio), AI modules (BioAgents at ai.bio.xyz, OpenLabs launched June 2026), collaborative research platforms (Science Beach with Molecule, launched March 2026), and the BIO token (max supply 3.32 billion, TGE January 2025, Coinbase-listed July 2025). The ecosystem comprises 11 vertical BioDAOs spanning longevity, brain health, hair loss, psychedelics, reproductive health, cryopreservation, synthetic biology, long COVID, quantum biology, and rare disease. Revenue is generated through a 1% trading fee on secondary BIO/Token liquidity pool transactions (30% retained by Bio.xyz) and a 2% launchpad fee on token launches; the platform does not charge for AI agent services directly. Distribution is non-custodial and self-serve through web interfaces (app.bio.xyz, ai.bio.xyz, gov.bio.xyz) and MetaMask-compatible wallets, with no sales force. The company is privately held, has 11-50 employees, and has raised $33M+ via the BIO Genesis initiative plus a disclosed $6.9M round in September 2025 led by Maelstrom, with prior backing from YZi Labs (formerly Binance Labs), Animoca Brands, and a $1M personal investment from Arthur Hayes.

Notable enterprise validation came via a November 2025 partnership with Pfizer for IP tokenization, and a concrete AI-driven discovery output — OX2R-004, an AI-generated peptide agonist for ADHD — was announced in April 2026. The platform restricts service in 29 jurisdictions including the United States and United Kingdom, which constrains the addressable retail market but does not limit the institutional and non-restricted-region user base.

Short descriptiontext

BIO Protocol is a decentralized science (DeSci) platform on Ethereum and Solana that enables patient, researcher, and crypto communities to fund and govern early-stage biotech research through BioDAOs and tokenized IP. It serves 11 vertical BioDAOs, integrates AI co-scientist agents, and monetizes via launchpad and trading fees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized science, biotech funding platform, DAO infrastructure, IP tokenization, AI drug discovery
Industry3 codes
PRIMARYFSADABAL
Launchpads, IDOs & Token Distribution via DEXs
Financial & Insurance/Crypto & Digital Assets/Decentralized Exchanges (DEX) & On-Chain Trading
SECONDARYFSAPAIAB
Consortium Networks & Governance (network setup, onboarding, rules, node operations)
Financial & Insurance/Blockchain & Web3/Enterprise Blockchain & Tokenization (permissioned networks, RWA tokenization)
SECONDARYFSADAEAN
RWA Settlement, Transfer Agent & Lifecycle Management Infrastructure
Financial & Insurance/Crypto & Digital Assets/Tokenization & Real-World Assets (RWA) Platforms
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Finance Services6199
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
  • Services-Commercial Physical & Biological Research8731
Product category
Decentralized Science Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Trading Fees
TypeTransaction Fee
Description

A 1% trading fee is applied automatically to all secondary market trades executed within the primary BIO/Token Liquidity Pool. Of collected fees, 70% is allocated to the Project's designated treasury wallet and 30% to Bio.xyz.

docs.bio.xyz
2Launchpad Fees
TypeTransaction Fee
Description

Bio Protocol charges a 2% fee on token launches conducted via the Launchpad V2, with 2% allocated to Bio.xyz as the standard launching fee.

docs.bio.xyz
3Staking Rewards
TypeSubscription Recurring
Description

Users can stake BIO tokens and ecosystem tokens to earn BioXP points, with staking mechanisms providing access to platform features and token launches that require an active staking position.

docs.bio.xyz
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Token Launch Participation via BioXP Allocation
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Token launches use BioXP points to determine allocation priority. Users pledge BioXP points and commit BIO tokens via smart contracts. 1% trading fee on secondary market trades in the primary BIO/Token pool.

docs.bio.xyz
2BioXP Staking Mechanism
ModelHybridBilling cadenceMonthly
Notes

Users earn BioXP through staking BIO (including veBIO conversions), staking ecosystem tokens, participating in token launches, and social engagement. BioXP expires after 7-90 days unless renewed through continued qualifying activity.

docs.bio.xyz
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 of 5 records shown
1BioXP
Description

BioXP is a point system within the Bio Protocol V2 platform used to determine allocation priority in token launches. Users accrue BioXP through staking BIO, staking ecosystem tokens, participating in token launches, and social engagement activities.

docs.bio.xyz
+4 more records
Core offering1 text field

BIO Protocol operates a decentralized science (DeSci) platform that provides a financial layer for funding and developing early-stage biotech research through tokenized intellectual property and Biotech Decentralized Autonomous Organizations (BioDAOs). The platform enables permissionless token launches via Launchpad V2, allocates participation priority through the BioXP point system, and supports AI-driven hypothesis generation through BioAgents including Aubrai (built with VitaDAO) and BIO Copilot. The protocol is deployed on Ethereum and Solana, governed by veBIO token holders, and generates revenue through trading and launchpad fees.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BIO Protocol is a decentralized science (DeSci) platform built on Ethereum and Solana that enables global communities of patients, researchers, and crypto users to fund and develop early-stage biotech through Biotech Decentralized Autonomous Organizations (BioDAOs). The platform's core product is the Bio Protocol infrastructure supporting multiple interconnected modules: Launchpad V2 (fixed-price token launch mechanism with BioXP point system and staking mechanisms), BioAgents (network of AI-powered scientific agents including Aubrai and BIO Copilot for hypothesis generation and research acceleration), Dashboard and Portfolio tools for ecosystem analytics, and the BIO token with veBIO governance mechanism. Additional offerings include OpenLabs (AI research hub for community funding), Science Beach (human-AI collaborative research platform), and the BIO Genesis initiative. The ecosystem encompasses 11 BioDAO projects focused on longevity, rare diseases, synthetic biology, brain health, hair loss, psychedelic research, cryopreservation, and quantum biology.

Product and service8 records
1Bio Protocol Core Platform
CategoryDecentralized Science Infrastructure
Description

Decentralized science (DeSci) platform built on Ethereum and Solana enabling community-driven funding and governance of biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs). Functions as financial infrastructure for biotech innovation using tokenized intellectual property and on-chain governance, used by researchers, patients, and crypto users globally.

2Launchpad V2
CategoryToken Launch Infrastructure
Description

Permissionless token launch platform featuring the Fixed Price Sale Launcher for curated fixed-price sales of newly issued tokens in exchange for BIO, the BioXP Point System for allocation priority, and staking mechanisms for BIO and ecosystem tokens. Used by researchers and BioDAOs to launch tokenized IP assets and raise funds from the BIO community.

3BioAgents
CategoryAI Research Tools
Description

Network of AI-powered scientific agents enabling hypothesis generation, funding coordination, and commercialization of biotech discoveries. Named agents include Aubrai (built with VitaDAO for longevity research) and BIO Copilot for research acceleration. Used by researchers and patients to access AI co-scientist capabilities for biotech research.

4OpenLabs
CategoryResearch Funding Platform
Description

AI research hub combining AI-assisted research development, community funding, and on-chain governance as an alternative to traditional grant-based research financing. Enables researchers to seek funding through community voting by BIO token holders, with flagship projects RheumaAI (autoimmune disease research) and PeptAI (peptide-based AI drug discovery).

5Science Beach
CategoryCollaborative Research Platform
Description

Open scientific public domain enabling collaboration between AI agents and humans on scientific hypotheses from initial ideas through IP funding. Launched with Molecule on Solana, the platform uses the BIOS economic coordination layer for research fee payments and result storage. Generated over 1,100 hypotheses with 59 AI agents and 55 users.

6Dashboard
CategoryAnalytics Platform
Description

Ecosystem analytics platform to track performance and key metrics of projects across the Bio ecosystem. Used by community members, researchers, and investors to monitor BioDAO projects, token performance, and platform statistics.

7Portfolio
CategoryPortfolio Management
Description

User portfolio tracking interface within the Bio app ecosystem, allowing individual users to monitor their token holdings, BioXP points, veBIO positions, and Launchpad allocations.

8BIO Genesis
CategoryFunding Initiative
Description

Initial genesis event and funding initiative for Bio Protocol that has raised over $33 million to support decentralized science projects through tokenized intellectual property and decentralized autonomous organization mechanisms.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-06
Description

Launched Science Beach, an open scientific public domain enabling AI-human collaboration on scientific hypotheses. Molecule deploys an autonomous agent for research fee payments and result storage while Bio Protocol provides the BIOS economic coordination layer.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-26
Description

Bio Protocol partnered with Pfizer on intellectual property tokenization for drug development, representing a significant validation of the DeSci model by a major pharmaceutical company.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-23
Description

VitaDAO partnered with Bio Protocol to build the AI-powered science agent Aubrai, combining longevity science expertise with AI-driven research capabilities.

Strategic tierCoreTypeOthers
Description

BioDAO focused on hair loss research operating within the Bio Protocol ecosystem with token (HAIR) launched via Launchpad.

5PsyDAO
Strategic tierCoreTypeOthers
Description

BioDAO focused on psychedelic research operating within the Bio Protocol ecosystem with token (PSY) launched via Launchpad.

docs.bio.xyz
Strategic tierCoreTypeOthers
Description

BioDAO focused on brain health that approved funding for a human clinical trial for a brain health supplement. Token (NEURON) launched via Launchpad.

Strategic tierCoreTypeOthers
Description

BioDAO focused on reproductive health research operating within the Bio Protocol ecosystem with token (ATH) launched via Launchpad.

Strategic tierCoreTypeOthers
Description

BioDAO focused on cryopreservation research operating within the Bio Protocol ecosystem with token (CRYO) launched via Launchpad.

Strategic tierCoreTypeOthers
Description

BioDAO focused on synthetic biology operating within the Bio Protocol ecosystem with token (GROW) launched via Launchpad.

Strategic tierCoreTypeOthers
Description

BioDAO focused on Long COVID research operating within the Bio Protocol ecosystem with token (COVID) launched via Launchpad.

11Quantum Biology DAO
Strategic tierCoreTypeOthers
Description

BioDAO focused on quantum biology research operating within the Bio Protocol ecosystem with token (QBIO) launched via Launchpad.

docs.bio.xyz
Strategic tierCoreTypeOthers
Description

ResearchHub is a partner BioDAO within the ecosystem focused on general scientific research funding and collaboration.

Strategic tierMinorTypeOthers
Description

BioDAO partner within the ecosystem focused on developing cures for various conditions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Molecule is a decentralized science (DeSci) platform for tokenizing biotech intellectual property via IP-NFTs, directly comparable to BIO Protocol's IP-token model. They are simultaneously a partner (Science Beach) and a direct competitor in DeSci IP tokenization infrastructure.

TypeDirect peer
Description

VitaDAO is the leading longevity-focused BioDAO and a core BIO Protocol ecosystem member that partnered on the AI agent Aubrai. It is directly comparable as a token-governed research funding DAO and one of BIO's flagship launchpad graduates.

TypeDirect peer
Description

ResearchHub is a partner BioDAO within BIO Protocol's ecosystem focused on general scientific research funding and collaboration, comparable as a community-driven, token-incentivized research platform overlapping BIO's DeScientists value proposition.

TypeDirect peer
Description

DAO Maker is a leading crypto launchpad and token offering platform with strong fee-based revenue from IDOs. Directly comparable to BIO Protocol's Launchpad V2 mechanics (fixed-price sales, allocation tiers, staking for priority).

TypeDirect peer
Description

Polkastarter is a multi-chain decentralized launchpad enabling permissionless token pools and fixed-weight swaps. Comparable to BIO Protocol's Launchpad V2 in mechanism (fixed-price token sales, DEX-based liquidity) and target audience (early-stage crypto projects).

TypeDirect peer
Description

Seedify is a crypto launchpad and incubator with tiered staking and IDO mechanics. Comparable to BIO Protocol in its launchpad-as-a-service model, staking-based allocation priority (analogous to BioXP), and fee revenue from token launches.

TypeDirect peer
Description

CerebrumDAO is a brain-health-focused BioDAO operating within BIO Protocol's ecosystem, with its own NEURON token launched via the Launchpad. Directly comparable as a vertical-specialized research DAO and a representative unit of BIO's 11-BioDAO network.

TypeBroad incumbent
Description

Ocean Protocol is an established decentralized data exchange for tokenizing datasets and data services. Comparable as a broader Web3 incumbent pursuing the tokenization of intangible assets (data vs. IP), though focused on data rather than biotech IP specifically.

TypeBroad incumbent
Description

SingularityNET is a decentralized AI services marketplace built on blockchain, with token-incentivized AI agent commerce. Comparable to BIO Protocol's BioAgents network as a blockchain-based marketplace for AI services, with overlap in the AI-agent monetization model.

TypeEmerging player
Description

Story Protocol is a Layer-1 blockchain purpose-built for tokenizing intellectual property across creative and technical domains. Comparable as an emerging player in IP tokenization with adjacent scope to BIO Protocol's biotech-specific IP-token model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors21 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIO Protocol

Decentralized Science Platformbio.xyz

BIO Protocol is a decentralized science (DeSci) platform on Ethereum and Solana that enables patient, researcher, and crypto communities to fund and govern early-stage biotech research through BioDAOs and tokenized IP. It serves 11 vertical BioDAOs, integrates AI co-scientist agents, and monetizes via launchpad and trading fees.

What BIO Protocol does

BIO Protocol, operated by the Swiss-domiciled BIO.XYZ Association in Zug, is a decentralized science (DeSci) platform built primarily on Ethereum with Solana expansion, that provides financial infrastructure for early-stage biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs) and tokenized intellectual property. The platform enables researchers to raise funds directly from global communities of patients, researchers, and crypto users, bypassing traditional grant gatekeepers and venture capital, while creating on-chain governance for research prioritization and commercialization. Core technology components include the Launchpad V2 (fixed-price token sale mechanism), BioXP (a non-transferable point system determining allocation priority in oversubscribed sales), veBIO (a 52-week vote-escrowed governance mechanism), and BioAgents — autonomous AI-powered scientific agents including Aubrai (built with VitaDAO for longevity) and BIO Copilot for hypothesis generation and research acceleration.

The product portfolio spans core protocol infrastructure (Launchpad V2, Dashboard, Portfolio), AI modules (BioAgents at ai.bio.xyz, OpenLabs launched June 2026), collaborative research platforms (Science Beach with Molecule, launched March 2026), and the BIO token (max supply 3.32 billion, TGE January 2025, Coinbase-listed July 2025). The ecosystem comprises 11 vertical BioDAOs spanning longevity, brain health, hair loss, psychedelics, reproductive health, cryopreservation, synthetic biology, long COVID, quantum biology, and rare disease. Revenue is generated through a 1% trading fee on secondary BIO/Token liquidity pool transactions (30% retained by Bio.xyz) and a 2% launchpad fee on token launches; the platform does not charge for AI agent services directly. Distribution is non-custodial and self-serve through web interfaces (app.bio.xyz, ai.bio.xyz, gov.bio.xyz) and MetaMask-compatible wallets, with no sales force. The company is privately held, has 11-50 employees, and has raised $33M+ via the BIO Genesis initiative plus a disclosed $6.9M round in September 2025 led by Maelstrom, with prior backing from YZi Labs (formerly Binance Labs), Animoca Brands, and a $1M personal investment from Arthur Hayes.

Notable enterprise validation came via a November 2025 partnership with Pfizer for IP tokenization, and a concrete AI-driven discovery output — OX2R-004, an AI-generated peptide agonist for ADHD — was announced in April 2026. The platform restricts service in 29 jurisdictions including the United States and United Kingdom, which constrains the addressable retail market but does not limit the institutional and non-restricted-region user base.

BIO Protocol firmographics

Firmographics
Name
BIO Protocol
Legal name
BIO.XYZ Association
Website
https://bio.xyz
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
BIO Protocol is a decentralized science (DeSci) platform on Ethereum and Solana that enables patient, researcher, and crypto communities to fund and govern early-stage biotech research through BioDAOs and tokenized IP. It serves 11 vertical BioDAOs, integrates AI co-scientist agents, and monetizes via launchpad and trading fees.
Ownership category
akta.pro rank

BIO Protocol industry classification

Industry
Product category
Decentralized Science Platform
NAICS
Computer Systems Design and Related Services (54151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Finance Services (6199), Security & Commodity Brokers, Dealers, Exchanges & Services (6200), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYFSADABAL
Launchpads, IDOs & Token Distribution via DEXs
Financial & Insurance/Crypto & Digital Assets/Decentralized Exchanges (DEX) & On-Chain Trading
SECONDARYFSAPAIAB
Consortium Networks & Governance (network setup, onboarding, rules, node operations)
Financial & Insurance/Blockchain & Web3/Enterprise Blockchain & Tokenization (permissioned networks, RWA tokenization)
SECONDARYFSADAEAN
RWA Settlement, Transfer Agent & Lifecycle Management Infrastructure
Financial & Insurance/Crypto & Digital Assets/Tokenization & Real-World Assets (RWA) Platforms

Keywords

  • Decentralized science
  • Biotech funding platform
  • DAO infrastructure
  • IP tokenization
  • AI drug discovery

Where BIO Protocol is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BIO Protocol business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Trading Fees: A 1% trading fee is applied automatically to all secondary market trades executed within the primary BIO/Token Liquidity Pool. Of collected fees, 70% is allocated to the Project's designated treasury wallet and 30% to Bio.xyz.
  2. Launchpad Fees: Bio Protocol charges a 2% fee on token launches conducted via the Launchpad V2, with 2% allocated to Bio.xyz as the standard launching fee.
  3. Staking Rewards: Users can stake BIO tokens and ecosystem tokens to earn BioXP points, with staking mechanisms providing access to platform features and token launches that require an active staking position.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goToken Launch Participation via BioXP Allocation
HybridMonthlyBioXP Staking Mechanism

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

BIO Protocol product offering

Product offering

Core offering

BIO Protocol operates a decentralized science (DeSci) platform that provides a financial layer for funding and developing early-stage biotech research through tokenized intellectual property and Biotech Decentralized Autonomous Organizations (BioDAOs). The platform enables permissionless token launches via Launchpad V2, allocates participation priority through the BioXP point system, and supports AI-driven hypothesis generation through BioAgents including Aubrai (built with VitaDAO) and BIO Copilot. The protocol is deployed on Ethereum and Solana, governed by veBIO token holders, and generates revenue through trading and launchpad fees.

Product overview

BIO Protocol is a decentralized science (DeSci) platform built on Ethereum and Solana that enables global communities of patients, researchers, and crypto users to fund and develop early-stage biotech through Biotech Decentralized Autonomous Organizations (BioDAOs). The platform's core product is the Bio Protocol infrastructure supporting multiple interconnected modules: Launchpad V2 (fixed-price token launch mechanism with BioXP point system and staking mechanisms), BioAgents (network of AI-powered scientific agents including Aubrai and BIO Copilot for hypothesis generation and research acceleration), Dashboard and Portfolio tools for ecosystem analytics, and the BIO token with veBIO governance mechanism. Additional offerings include OpenLabs (AI research hub for community funding), Science Beach (human-AI collaborative research platform), and the BIO Genesis initiative. The ecosystem encompasses 11 BioDAO projects focused on longevity, rare diseases, synthetic biology, brain health, hair loss, psychedelic research, cryopreservation, and quantum biology.

Differentiator

Problem solved

Functional benefit

Brands

  • BioXP: BioXP is a point system within the Bio Protocol V2 platform used to determine allocation priority in token launches. Users accrue BioXP through staking BIO, staking ecosystem tokens, participating in token launches, and social engagement activities.
  • BioAgents
  • BioDAOs
  • OpenLabs
  • Science Beach

Products and services

  • Bio Protocol Core Platform Decentralized science (DeSci) platform built on Ethereum and Solana enabling community-driven funding and governance of biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs). Functions as financial infrastructure for biotech innovation using tokenized intellectual property and on-chain governance, used by researchers, patients, and crypto users globally.
  • Launchpad V2 Permissionless token launch platform featuring the Fixed Price Sale Launcher for curated fixed-price sales of newly issued tokens in exchange for BIO, the BioXP Point System for allocation priority, and staking mechanisms for BIO and ecosystem tokens. Used by researchers and BioDAOs to launch tokenized IP assets and raise funds from the BIO community.
  • BioAgents Network of AI-powered scientific agents enabling hypothesis generation, funding coordination, and commercialization of biotech discoveries. Named agents include Aubrai (built with VitaDAO for longevity research) and BIO Copilot for research acceleration. Used by researchers and patients to access AI co-scientist capabilities for biotech research.
  • OpenLabs AI research hub combining AI-assisted research development, community funding, and on-chain governance as an alternative to traditional grant-based research financing. Enables researchers to seek funding through community voting by BIO token holders, with flagship projects RheumaAI (autoimmune disease research) and PeptAI (peptide-based AI drug discovery).
  • Science Beach Open scientific public domain enabling collaboration between AI agents and humans on scientific hypotheses from initial ideas through IP funding. Launched with Molecule on Solana, the platform uses the BIOS economic coordination layer for research fee payments and result storage. Generated over 1,100 hypotheses with 59 AI agents and 55 users.
  • Dashboard Ecosystem analytics platform to track performance and key metrics of projects across the Bio ecosystem. Used by community members, researchers, and investors to monitor BioDAO projects, token performance, and platform statistics.
  • Portfolio User portfolio tracking interface within the Bio app ecosystem, allowing individual users to monitor their token holdings, BioXP points, veBIO positions, and Launchpad allocations.
  • BIO Genesis Initial genesis event and funding initiative for Bio Protocol that has raised over $33 million to support decentralized science projects through tokenized intellectual property and decentralized autonomous organization mechanisms.

Companies that use BIO Protocol

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

BIO Protocol technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

BIO Protocol partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Molecule (on Solana)coreStrategic or Co-development Partner · 6 March 2026Launched Science Beach, an open scientific public domain enabling AI-human collaboration on scientific hypotheses. Molecule deploys an autonomous agent for research fee payments and result storage while Bio Protocol provides the BIOS economic coordination layer.
  • PfizercoreStrategic or Co-development Partner · 26 August 2025Bio Protocol partnered with Pfizer on intellectual property tokenization for drug development, representing a significant validation of the DeSci model by a major pharmaceutical company.
  • VitaDAOcoreStrategic or Co-development Partner · 23 August 2025VitaDAO partnered with Bio Protocol to build the AI-powered science agent Aubrai, combining longevity science expertise with AI-driven research capabilities.
  • HairDAOcoreOthersBioDAO focused on hair loss research operating within the Bio Protocol ecosystem with token (HAIR) launched via Launchpad.
  • PsyDAOcoreOthersBioDAO focused on psychedelic research operating within the Bio Protocol ecosystem with token (PSY) launched via Launchpad.
  • CerebrumDAOcoreOthersBioDAO focused on brain health that approved funding for a human clinical trial for a brain health supplement. Token (NEURON) launched via Launchpad.
  • AthenaDAOcoreOthersBioDAO focused on reproductive health research operating within the Bio Protocol ecosystem with token (ATH) launched via Launchpad.
  • CryoDAOcoreOthersBioDAO focused on cryopreservation research operating within the Bio Protocol ecosystem with token (CRYO) launched via Launchpad.
  • ValleyDAOcoreOthersBioDAO focused on synthetic biology operating within the Bio Protocol ecosystem with token (GROW) launched via Launchpad.
  • Long COVID LabscoreOthersBioDAO focused on Long COVID research operating within the Bio Protocol ecosystem with token (COVID) launched via Launchpad.
  • Quantum Biology DAOcoreOthersBioDAO focused on quantum biology research operating within the Bio Protocol ecosystem with token (QBIO) launched via Launchpad.
  • ResearchHubcoreOthersResearchHub is a partner BioDAO within the ecosystem focused on general scientific research funding and collaboration.
  • CuretopiaminorOthersBioDAO partner within the ecosystem focused on developing cures for various conditions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

BIO Protocol competitors and assessment

Company assessment

Direct peers

  • Molecule: Molecule is a decentralized science (DeSci) platform for tokenizing biotech intellectual property via IP-NFTs, directly comparable to BIO Protocol's IP-token model. They are simultaneously a partner (Science Beach) and a direct competitor in DeSci IP tokenization infrastructure.
  • VitaDAO: VitaDAO is the leading longevity-focused BioDAO and a core BIO Protocol ecosystem member that partnered on the AI agent Aubrai. It is directly comparable as a token-governed research funding DAO and one of BIO's flagship launchpad graduates.
  • ResearchHub: ResearchHub is a partner BioDAO within BIO Protocol's ecosystem focused on general scientific research funding and collaboration, comparable as a community-driven, token-incentivized research platform overlapping BIO's DeScientists value proposition.
  • DAO Maker: DAO Maker is a leading crypto launchpad and token offering platform with strong fee-based revenue from IDOs. Directly comparable to BIO Protocol's Launchpad V2 mechanics (fixed-price sales, allocation tiers, staking for priority).
  • Polkastarter: Polkastarter is a multi-chain decentralized launchpad enabling permissionless token pools and fixed-weight swaps. Comparable to BIO Protocol's Launchpad V2 in mechanism (fixed-price token sales, DEX-based liquidity) and target audience (early-stage crypto projects).
  • Seedify: Seedify is a crypto launchpad and incubator with tiered staking and IDO mechanics. Comparable to BIO Protocol in its launchpad-as-a-service model, staking-based allocation priority (analogous to BioXP), and fee revenue from token launches.
  • CerebrumDAO: CerebrumDAO is a brain-health-focused BioDAO operating within BIO Protocol's ecosystem, with its own NEURON token launched via the Launchpad. Directly comparable as a vertical-specialized research DAO and a representative unit of BIO's 11-BioDAO network.

Broad incumbents

  • Ocean Protocol: Ocean Protocol is an established decentralized data exchange for tokenizing datasets and data services. Comparable as a broader Web3 incumbent pursuing the tokenization of intangible assets (data vs. IP), though focused on data rather than biotech IP specifically.
  • SingularityNET: SingularityNET is a decentralized AI services marketplace built on blockchain, with token-incentivized AI agent commerce. Comparable to BIO Protocol's BioAgents network as a blockchain-based marketplace for AI services, with overlap in the AI-agent monetization model.

Emerging players

  • Story Protocol: Story Protocol is a Layer-1 blockchain purpose-built for tokenizing intellectual property across creative and technical domains. Comparable as an emerging player in IP tokenization with adjacent scope to BIO Protocol's biotech-specific IP-token model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BIO Protocol social profiles

Digital presence

BIO Protocol compliance and trust

Trust signal

Compliance1 record

BIO Protocol financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIO Protocol leadership team

Management profile

Number of profiles

Profiles3 records

BIO Protocol subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

BIO Protocol funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIO Protocol M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO Protocol

What does BIO Protocol do?

BIO Protocol operates a decentralized science (DeSci) platform that provides a financial layer for funding and developing early-stage biotech research through tokenized intellectual property and Biotech Decentralized Autonomous Organizations (BioDAOs). The platform enables permissionless token launches via Launchpad V2, allocates participation priority through the BioXP point system, and supports AI-driven hypothesis generation through BioAgents including Aubrai (built with VitaDAO) and BIO Copilot. The protocol is deployed on Ethereum and Solana, governed by veBIO token holders, and generates revenue through trading and launchpad fees.

Is BIO Protocol a public or private company?

BIO Protocol is a private company. It is classified as venture growth investor backed and is currently operating.

When was BIO Protocol founded?

BIO Protocol was founded in 2022. It employs 11 to 50 people.

Where is BIO Protocol based?

BIO Protocol is headquartered in New York, United States, in the North America region.

How does BIO Protocol make money?

Three revenue lines are on record. Trading Fees are the primary driver. The others are launchpad Fees and staking Rewards.

Who are BIO Protocol's main competitors?

Direct peers on record are Molecule, VitaDAO, ResearchHub, DAO Maker, Polkastarter, Seedify and CerebrumDAO. Broad incumbents are Ocean Protocol and SingularityNET. Story Protocol is listed as an emerging player.

Does BIO Protocol have an API?

No public API is recorded for BIO Protocol.

What industry is BIO Protocol in?

BIO Protocol's product category is Decentralized Science Platform. Its primary akta.pro industry code is FSADABAL, Launchpads, IDOs & Token Distribution via DEXs, with a secondary code of FSAPAIAB, Consortium Networks & Governance (network setup, onboarding, rules, node operations). Its NAICS code is 54151 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestBio Protocol Trades Near $0.03 as Volume VanishesBio Protocol trades near $0.03065 with 24-hour turnover of about $1,800, far below 7-day and 15-day averages. A bullish engulfing candle on Oct 4 suggests short-term buyer interest, but price faces rejection at $0.031 resistance with support at $0.03029. Low volume makes any break fragile and prone to false signals.AInvestBio Protocol Surges on 30x Volume Spike, Challenging DowntrendBio Protocol/USDC surged to $0.02859 on a 30x volume spike at 07:00 ET, breaking above key resistance. The 7-day rally is +11.85%, but a 15-day lower-low trend persists. Price tests $0.0286 resistance, with upside toward $0.0290 or pullback to $0.0273.AInvestBio Protocol (BIO) Rallies 21% in a Week on Coinbase Listing and DeSci Narrative Momentum -- Is the Run Sustainable?Bio Protocol's token BIO has increased by 21% over a week following its listing on Coinbase and other catalysts like the OpenLabs AI research hub launch and a planned MicrobiomeDAO launch. Despite the rally, the token remains 97% below its all-time high, with significant locked supply and the DeSci sector still considered experimental.CoinMarketCapWhat Is Decentralized Science (DeSci) and How Does It Work?: Guest Post by 36cryptoDecentralized science (DeSci) utilizes blockchain technology and Web3 infrastructure to enhance transparency and accessibility in scientific research funding. Notable platforms such as BIO Protocol, Molecule, VitaDAO, and AminoChain exemplify the application of decentralized methods in various scientific fields, although challenges like research quality and regulatory uncertainty persist. This emerging model aims to connect researchers directly with funding communities, reducing reliance on traditional institutions.AInvestWhite House Targets $200B Science Budget as Bio Protocol Scales DeSci Funding Past $33MThe White House is directing approximately $200 billion in annual R&D funding toward individual scientists rather than universities, prioritizing fellowships and awards over institutional grants. Bio Protocol has raised $33 million through its BIO Genesis initiative and launched OpenLabs, a platform enabling AI-assisted research, community funding, and token-based governance. Critics argue the thesis remains early-stage and question whether decentralized funding can demonstrate real-world research impact compared to traditional grant systems.Crypto BriefingBio Protocol builds onchain science model as White House pushes to reform $200B in research fundingBio Protocol operates as a decentralized science (DeSci) platform that uses onchain systems to fund, govern, and coordinate biotech research, having facilitated over $900,000 in research funding and minted more than 1,000 hypotheses onchain. A July 2026 federal report from the Office of Science and Technology Policy calls for redirecting approximately $200 billion in annual federal R&D spending toward direct grants to individual researchers, cutting out institutional bureaucracy, creating thematic alignment with Bio Protocol's model though without official endorsement. The platform raised $6.9 million in seed funding in September 2025 led by Maelstrom Fund, with participation from Mechanism Capital and Animoca Brands, and supports cumulative research initiatives valued between $15 million and $34 million.链捕手 ChainCatcherBio Protocol launches OpenLabs, aiming to support scientific projects and agent collaboration through the USDC revenue mechanismBio Protocol announced the launch of OpenLabs, a decentralized science coordination layer enabling collaboration between humans and AI agents in scientific research, structured across five interconnected layers including discovery, projects, agent collaboration, Web3 incentives, and bounty systems. The platform employs a USDC yield-based financing mechanism, depositing user funds into audited vaults like Morpho and Aave to generate yields that fund agent reasoning, computation, and research queries without principal risk to depositors. Projects reaching advanced stages can subsequently issue tokens via Bio's launchpad or pursue traditional biotech financing paths.VerificationBio Protocol 推出 OpenLabs,计划通过 USDC 收益机制资助 AI Agent 科研协作Bio Protocol launched OpenLabs, a platform connecting scientific ideas with funding execution for human-AI agent collaboration. It uses USDC yield-based financing, where users stake USDC to support projects, with yields funding AI agent inference and tool costs. The platform is live with initial projects displayed.BitgetBio Protocol develops AI agents to enhance decentralized science operationsBio Protocol has launched BioAgents and an AI intelligence layer called Gaia to enhance decentralized science operations, providing AI co-scientists capable of analyzing literature, supporting governance decisions, and coordinating scientific workflows. The platform raised $6.9 million in September 2025, led by Arthur Hayes' Maelstrom with support from Binance Labs/YZi Labs, and ecosystem projects have collectively raised over $33 million. Strategic partnerships with VitaDAO and Molecule complement the ecosystem, with the BIO token serving as the economic core for incentivizing AI agents and accessing funding launchpads.